· Public charity
Global Genes
GLOBAL GENES' mission is to drive change through the support of rare disease patients and families while equipping advocacy leaders with important tools, resources, mentoring, and connections to further advance awareness, education, and research.
What you funded, over time
Every grant placed by its stated purpose and the recipient’s mission, by year — across FY2017–2024.
Where the money goes
Your grants by size, and where they go.
The 7 grants below total $60,750 — the rows itemised in this filing. The $175,264 headline is the total grant expense reported on the return, so the remaining $114,514 is giving the schedule does not break out: grants under the $5,000 itemisation floor, grants to individuals, and grants reported on other schedules. Every figure below describes the itemised rows only.
| Recipient | Amount |
|---|---|
| PEDIATRIC BRAIN TUMOR FOUNDATION | $9,000 |
| THE ALLO HOPE FOUNDATION | $9,000 |
| LHON COLLECTIVE | $9,000 |
| THE SUMAIRA FOUNDATION | $9,000 |
| OXALOSIS & HYPEROXALURIA FOUNDATION | $9,000 |
| NATIONAL FOUNDATION FOR ECTODERMAL DYSPLASIAS | $9,000 |
| CURE JM FOUNDATION | $6,750 |
Do your dollars go where the need is?
Each grant placed by the hardship in its grantee’s ZIP, then read against the area’s typical level.
Your human-services grants (FY19–20, $40k) land where the poverty rate runs at 10%, against an area that typically sits at 10%. 38% of those dollars go to grantees based in above-average-need neighborhoods. Your grants skew toward lower-need ZIPs.
Matched: human-services grants are those whose grantee’s IRS cause code is Human Services. Placed by people below the poverty linein the grantee’s ZIP, averaged from the tracts in that ZIP; grantee ZIP can differ from where services are delivered.
Which US states your grants reach
US grants placed by each grantee’s ZIP, which can differ from where services are actually delivered. Need from public data — U.S. Census/ACS, CDC PLACES, Eviction Lab, USDA — shown as context about the area, never attributed to your giving.
Who you back again
Which organizations you funded more than once, and which you funded a single time. Each grantee is matched to its own filings.
And the relationships you keep tend to grow: grantees you re-up on have seen median revenue of +46% since the first grant, against +32% for the ones you funded once.
22 repeat relationships — 0 still active in FY2024, 22 since wound down; 7 grantees were first funded in FY2024 (too recent to call).
How the two cohorts compare
Organizations
Total granted
Median revenue growth · since first grant
Still filing today
New vs renewed · share of each year
In FY2024, 0% of grant dollars renewed an existing relationship; $61k went to new ones.
Where new relationships form · theme of each grantee’s first grant
First-time = a grantee’s first year in your filing window; renewed = funded in an earlier year too. As a portfolio matures the renewed share naturally climbs — once funded, an org stays “renewable” — so the signal is the years that buck it (a new-grantee intake wave). The earliest year is left-censored: relationships that predate the data read as “new.” Theme is the grantee’s IRS cause.
Backed again, and grew
- FHflok Health FKA NATIONAL PKU NEWS3× · 2019–2021 · $48k · revenue +448%
- TTTeam Telomere Inc4× · 2019–2023 · $47k · revenue +154%
- ASANGELMAN SYNDROME FOUNDATION INC3× · 2020–2023 · $43k · revenue +110%
Funded once
- RRARE-Xone grant, 2019 · $118k
- GPGLOBAL PEDIATRIC MDS INITIATIVE INCone grant, 2021 · $58k · 97% of their budget
- OFOrganization for Rare Diseaseone grant, 2019 · $38k
Repeat = funded in two or more distinct years; growth and survival are read from each grantee’s own subsequent IRS filings.
The map has a center of gravity: the average direction from the rest of the sector toward the organizations the foundation funds — the shape of its giving. Scoring every nonprofit along that direction surfaces the ones that look most like the portfolio. These are the closest matchesthat aren’t grantees — a resemblance in what they say they do, not a recommendation.
To find cure for adssl1 and offer hope and provide a brighter future to children affected with adenylosuccinate lyase (adsl) deficiency
Cure Rare Foundation, established in Spring 2022, is a nonprofit organization devoted to funding the research and development of treatments and cures for rare genetic diseases. In the United States, diseases are considered rare when a…
Kfiaf is a patient advocacy group providing education about the rare disease kcnma1 linked channelopathy to families and healthcare workers, as well as helping to promote and facilitate research in this area. we communicate through…
To cure cf and provide all people with cf the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the cf community, and advancing high-quality, specialized care.
To find specific treatment options and a cure for CACNA1A patients. (See Schedule O for full mission)
MLD Foundation works with families, researchers, regulators, industry, and policy-makers to improve the quality of life for those with MLD including standards of clinical care and clinical research excellence, develop and implement newborn…
The mission of mila's miracle foundation is to find and fund paths to a cure for batten and other life-threatening neurological disorders. families in this community have been pivotal in raising the necessary funds and awareness. together,…
Support undiagnosed and rare disease patients and famil
ADCY5.org supports the following groups: families affected by the ADCY5 gene variant rare disease, clinicians treating patients, and researchers pursuing treatments. We achieve our goals through collaboration, or funding efforts. We look…
SMC1A Foundation is a Non-Profit Organization with the vision to bring awareness, accelerate research, and find a cure for SMC1A, and ultimately transform the lives of those affected. Our goal is to raise funds for research. 100 percent of…
The mission of curecadasil is to raise awareness of cadasil, ensuring it will be universally recognized and understood by the medical community, enabling patients to be correctly diagnosed. we are dedicated to helping all touched by…
For reference, the grantee most central to the portfolio’s shape is Angelman Syndrome Foundation Inc and the most unlike its peers is Asociacion Puertorriquena De Hemofilia Inc. Resemblance is measured on each organization’s own IRS 990 mission text; it reflects how work is described, not its quality or impact.
For each theme you fund, this compares how the sector’s money is shifting with how your own giving is shifting.
Sector change and giving change are each shown relative to their own range, growing (right) or shrinking (left); both normalized, so inflation isn’t mistaken for growth.
Your grantees are a median of 16 years old; the field is 16. You back the younger end — and your money leans older still.
The field is 22% startups (under 5 years old) — 0% of your grantees by number, and just 0% of your money.
The orgs you fund almost never close — 0.8% lost their exemption, against 13% of the field you don’t fund.
Age = years since IRS exemption (a founding proxy). “Closed” = auto-revocation for 3 years of non-filing — a floor on closure, not proof, and bigger established orgs lapse least. Association, not causation.
114 grantees tracked through their own filings, 2017–2026.
Each one resolved to its own IRS returns and tracked year by year — your grant beside their revenue from every source. Association, dated; never a causal claim.
Counted here: distinct organizations you funded across 2017–2026, not grant rows in a single year — so this will not match the grant count on the cover. 114 of the 125 grantees resolved in that span have returns of their own we could reconcile; the rest are funded organizations whose filings we could not track year by year.
Where your money sits — by cause, then by grantee
Each org by its size and your share of it — top-left is where you’re load-bearing
Go grantee by grantee — a decade per org, and how each moved after you funded them
A decade per grantee — revenue shaded, your grants as bars, all rows on one timeline.
- Who funds RARE-X ↗
- Who funds GLOBAL PEDIATRIC MDS INITIATIVE INC ↗
- Who funds flok Health FKA NATIONAL PKU NEWS ↗
- Who funds Team Telomere Inc ↗
- Who funds ANGELMAN SYNDROME FOUNDATION INC ↗
- Who funds BRAIN RECOVERY PROJECT ↗
- Who funds HELPING HANDS FOR GAND INC ↗
- Who funds GLOBAL FOUNDATION FOR PEROXISOMAL DISORDERS ↗
- Who funds FOUNDATION FOR SARCOIDOSIS RESEARCH ↗
- Who funds ANGIOMA ALLIANCE DBA ALLIANCE TO CURE CAVERNOUS MALFORMATIONS ↗
- Who funds CARDIO-FACIO-CUTANEOUS INTERNATIONAL ↗
- Who funds PHELAN MCDERMID SYNDROME FOUNDATION ↗
- Who funds DREAMSICKLE KIDS FOUNDATION ↗
- Who funds CONGENITAL HYPERINSULINISM INTERNATIONAL ↗
- Who funds CYSTIC FIBROSIS RESEARCH INSTITUTE ↗
- Who funds Progressive Familial Intrahepatic Cholestasis ↗
- Who funds COALITION FOR USHER SYNDROME RESEARCH ↗
- Who funds OUR ODYSSEY INC ↗
- Who funds AKARI FOUNDATION ↗
- Who funds SATB2 Gene Foundation Inc ↗
- Who funds South Central Pennsylvania Sickle Cell Council ↗
- Who funds BREATHESTRONG CF INC ↗
- Who funds THE FAMILIESCN2A FOUNDATION INC ↗
- Who funds Sickle Cell Disease Association of America Inc ↗
- Who funds Illinois Spina Bifida Association ↗
- Who funds THE MARFAN FOUNDATION INC ↗
- Who funds MITOACTION INC ↗
- Who funds RIDE FOR LIFE INC ↗
- Who funds HEMOPHILIA FOUNDATION OF SOUTHERN CALIFORNIA ↗
- Who funds ALAGILLE SYNDROME ALLIANCE ↗
- Who funds SETBP1 SOCIETY ↗
- Who funds KIF1AORG INC ↗
- Who funds THE FIBROUS DYSPLASIA FOUNDATION ↗
- Who funds FIGHTING FOR KAIDEN FOUNDATION INC ↗
- Who funds The Myositis Association ↗
- Who funds ADRENAL INSUFFICIENCY UNITED ↗
- Who funds XLH NETWORK INC ↗
The grantmakers whose grantees overlap with yours far more than size alone predicts. Each orbits closer the stronger the alignment; the arcs between them show where they also fund each other. Here it reads as a tightly interlocked camp — most of these funders back each other's grantees too.
Open a dossier: Silicon Valley Community Foundation · The Simons Foundation Inc · AbbVie Foundation · Child Neurology Education and Research Foundation · American Express Foundation · The Pfizer Foundation Inc · The Lazard Charitable Foundation · Global Impact · Shell USA Company Foundation · McKesson Foundation Inc · Paypal Charitable Giving Fund · Hemophilia Federation of America
Affinity is a Gamma-Poisson posterior co-funding rate, re-centered on the typical rate, so thin evidence shrinks toward no signal. A research starting point: overlap is association, not proof of shared intent.
Government reliance of your grantees
Every dot is one organization Global Genes funds. Left–right is the share of its income from government; up–down is the share from you. Bigger dots raise more. Filter to federal, a single department, or state — and drag the year to watch it move.
- Ch Neurology Foundation Inc — 1% of income from government
- Raymond a Wood Foundation Inc — 0% of income from government
Government income is each org’s traced federal awards (USASpending — grants and contracts) plus state payments (open checkbooks) as a share of its total revenue (IRS Form 990); the self-reported government-grant line (990 line 1e) is carried for cross-check: a grantee that reports government grants we could not trace to a source is left off the chart rather than shown as receiving none. An association, not a claim that your grant caused the public funding. Coverage is precision-first — a floor, not a census; state records exist for 9 states, so a grantee outside them shows no state figure (dimmed) rather than a false zero. Federal award amounts are obligations, which can span years, so a single-year share is indicative. 990 filings lag 12–24 months.